Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D.

[1]  Á. Soriano,et al.  Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation , 2020, The journal of vascular access.

[2]  A. El-Hennawy,et al.  Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  A. Hamad,et al.  Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  W. Winnicki,et al.  Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. , 2017, Kidney international.

[5]  Á. Soriano,et al.  Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis Patients , 2014, Antimicrobial Agents and Chemotherapy.

[6]  M. Jadoul,et al.  Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  M. Allon.  Dialysis catheter-related bacteremia: treatment and prophylaxis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  M. Taylor,et al.  Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. , 2002, Kidney international.

[9]  E W Young,et al.  Type of vascular access and mortality in U.S. hemodialysis patients. , 2001, Kidney international.